LINACS
LINACS Home
OligoCare
Group

Therapeutic Vaccines

Study design
RT–Drug Timing Window
The data above refer to patients treated with Therapeutic Vaccines as the sole drug class, excluding any concurrent use of drugs from other groups.
Individual Drugs

Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.